ISSN 0303-5212
 

Original Research 
RMJ. 2025; 50(3): 610-614


Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis

Muhammad Ali, Mahjabeen Yaseen, Saba Aziz, Ayesha Aijaz, Abdul Manan Junejo, Hina Iram.


Abstract
Objective: To assess the frequency of hepatitis-c reinfection after treatment with direct-acting antiviral (DAA) therapy undergoing maintenance hemodialysis.
Methodology: This observational, cross-sectional study included 160 patients in the Department of Nephrology, JPMC, from November 2019 to October 2020. The sampling technique used was non-probability. Demographic information, such as age, gender, HCV genotype, HCV RNA, and comorbidities, was gathered from the medical data or by interviews with patients and family members.
Results: The severity of liver disease was classified according to the Child-Turcotte-Pugh (CTP) score. We found that 38.9% patients had an average score of 6, and 53.7% were classified in CTP class A. The re-infection rate of HCV was very low after treatment with DAA.
Conclusion: DAAs have become a successful treatment for HCV, allowing the virus to be eradicated.

Key words: Reinfection, hepatitis c, Sofosbuvir, hemodialysis, virological response.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Muhammad Ali
Articles by Mahjabeen Yaseen
Articles by Saba Aziz
Articles by Ayesha Aijaz
Articles by Abdul Manan Junejo
Articles by Hina Iram
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Ali M, Yaseen M, Aziz S, Aijaz A, Junejo AM, Iram H. Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. RMJ. 2025; 50(3): 610-614.


Web Style

Ali M, Yaseen M, Aziz S, Aijaz A, Junejo AM, Iram H. Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. https://www.rmj.org.pk/?mno=214498 [Access: October 29, 2025].


AMA (American Medical Association) Style

Ali M, Yaseen M, Aziz S, Aijaz A, Junejo AM, Iram H. Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. RMJ. 2025; 50(3): 610-614.



Vancouver/ICMJE Style

Ali M, Yaseen M, Aziz S, Aijaz A, Junejo AM, Iram H. Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. RMJ. (2025), [cited October 29, 2025]; 50(3): 610-614.



Harvard Style

Ali, M., Yaseen, . M., Aziz, . S., Aijaz, . A., Junejo, . A. M. & Iram, . H. (2025) Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. RMJ, 50 (3), 610-614.



Turabian Style

Ali, Muhammad, Mahjabeen Yaseen, Saba Aziz, Ayesha Aijaz, Abdul Manan Junejo, and Hina Iram. 2025. Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. Rawal Medical Journal, 50 (3), 610-614.



Chicago Style

Ali, Muhammad, Mahjabeen Yaseen, Saba Aziz, Ayesha Aijaz, Abdul Manan Junejo, and Hina Iram. "Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis." Rawal Medical Journal 50 (2025), 610-614.



MLA (The Modern Language Association) Style

Ali, Muhammad, Mahjabeen Yaseen, Saba Aziz, Ayesha Aijaz, Abdul Manan Junejo, and Hina Iram. "Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis." Rawal Medical Journal 50.3 (2025), 610-614. Print.



APA (American Psychological Association) Style

Ali, M., Yaseen, . M., Aziz, . S., Aijaz, . A., Junejo, . A. M. & Iram, . H. (2025) Frequency of hepatitis-c reinfection after treatment with direct-acting antiviral therapy undergoing maintenance hemodialysis. Rawal Medical Journal, 50 (3), 610-614.